Seema Dawood/LinkedIn
Aug 7, 2026, 15:54
Seema Dawood: Why the Peripheral Blood Smear Still Matters in the Age of Automation?
Seema Dawood, Medical Laboratory Technologist at The Aga Khan University Hospital, shared a post on LinkedIn:
“Why the Peripheral Blood Smear Still Matters in the Age of Automation??
Modern hematology analyzers are fast, precise, and flag abnormalities in seconds. But they still can’t replace what a trained eye sees under the microscope.
A smear tells the story numbers alone can’t:
- Red cell morphology — target cells, schistocytes, sickle cells
- True platelet clumping vs. pseudo-thrombocytopenia
- Blast cells an analyzer might just flag as ‘abnormal lymphocyte’
- Parasites like malaria — invisible to the machine entirely
- In hematology, automation gives you speed but the smear gives you certainty.
Some things in diagnostics just aren’t meant to be fully automated.”
Other posts featuring Seema Dawood on Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke